Associated Papers
Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.
Boot A et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
35058360 (PubMed )
Supplement: pnas.2114024119.sd08.xlsx › Dataset.S8
Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome.
Li Y et al.
Frontiers in Oncology, 2021
34660315 (PubMed )
Supplement: DataSheet_1.zip › original_data › 1_Plus_P2011140015___________panel825plus_2020.11.20-final.pdf
Select a paper to view details